NCT05210764

Brief Summary

The change profiles of indices derived from pEEG such as phase-amplitude coupling and bicoherence based on individual general anesthetics in children have not been examined in previous literature. Whether those indices have the abilities to predict individual drug-related anesthesia depth in children need to be explored.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
366

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Jun 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jun 2022Aug 2026

First Submitted

Initial submission to the registry

January 9, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

3.8 years

First QC Date

January 9, 2022

Last Update Submit

July 28, 2025

Conditions

Keywords

general anestheticelectroencephalogram

Outcome Measures

Primary Outcomes (4)

  • phase-amplitude coupling

    phase-amplitude coupling

    induction, maintenance, and recovery of anesthesia

  • bicoherence

    bicoherence

    induction and maintenance, and recovery of anesthesia

  • spectral analysis

    spectral analysis

    induction and maintenance, and recovery of anesthesia

  • entropy indices

    entropy indices

    induction and maintenance, and recovery of anesthesia

Study Arms (3)

propofol

General anesthesia is induced and maintained mainly with propofol.

Drug: propofol

sevoflurane

General anesthesia is induced and maintained mainly with sevoflurane.

Drug: sevoflurane

ketamine

General anesthesia is induced mainly with S-ketamine and maintained mainly with propofol.

Drug: S-ketamine

Interventions

General anesthesia is induced and maintained mainly with propofol.

Also known as: Propofol anesthesia group
propofol

General anesthesia is induced and maintained mainly with sevoflurane.

Also known as: Sevoflurane anesthesia group
sevoflurane

General anesthesia is induced mainly with S-ketamine and maintained mainly with propofol.

Also known as: S-ketamine anesthesia group
ketamine

Eligibility Criteria

Age1 Minute - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients aged 0-18 years, American Society of Anesthesiologists Physical Status I-II, scheduled for elective surgery in Peking University First Hospital

You may qualify if:

  • patients aged 0-18 years, American Society of Anesthesiologists Physical Status I-II, scheduled for elective surgery in Peking University First Hospital.

You may not qualify if:

  • Preterm patients;
  • Height and weight not within the standard ranges for respective ages;
  • Surgery for head or heart;
  • Patients with muscular, neurologic or psychiatric diseases;
  • Patients with Congenital anomaly or hereditary diseases;
  • Patients with medication abuse;
  • Allergy to medication including propofol, sevoflurane, and ketamine;
  • Allergy to beans;
  • Refusal to participate the study by guardians.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University First Hospital

Beijing, China

RECRUITING

MeSH Terms

Interventions

PropofolSevofluraneEsketamine

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Dong-Xin Wang, MD, PhD

    Peking University First Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 9, 2022

First Posted

January 27, 2022

Study Start

June 1, 2022

Primary Completion

March 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations